|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 18 CNY | +4.23% |
|
+10.70% | -27.91% |
| Apr. 23 | LBP Medicine Scraps Convertible Bonds Issuance Plans | MT |
| Apr. 19 | LBP Medicine Gets Certificate for HER2 Antibody Reagent | MT |
Guangzhou LBP Medicine Science & Technology Co., Ltd. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was CNY 507.04 million compared to CNY 438.99 million a year ago. Net income was CNY 43.41 million compared to CNY 79.78 million a year ago.
Basic earnings per share from continuing operations was CNY 0.47 compared to CNY 0.85 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -27.91% | 232M | |
| +1.19% | 12.8B | |
| -10.29% | 7.61B | |
| +3.32% | 5.41B | |
| -1.16% | 4.51B | |
| +5.74% | 4.49B | |
| +12.21% | 2.73B | |
| -14.54% | 2.02B | |
| -11.50% | 1.73B | |
| -5.02% | 1.64B |
GUANGZHOU LBP MEDICINE SCIENCE & TECHNOLOGY CO., LTD. 
